LIVE

/Stellar Crown/Medicham ex

Variants

STANDARD · Conviction 5/10

Medicham ex

Stellar Crown · #161 · Ultra Rare

Reference NM

€1.07

External reference · raw NM

PSA 9

€6.16

USD source

PSA 10

€30.61

USD source

Composite

5.1

Confidence 5/10

5.1

Live raw NM price unavailable from primary source — showing external reference.

View listing →View price reference →

Buy range€1.29 – €1.69Good buy

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

5.1

SCORE / 10

Liquidity

10.0

Scarcity

9.8

Era potential

5.6

Friction

7.1

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 50.87%Total population

PSA 10

204

PSA 9

167

PSA 8

Total graded

401

Gem rate 50.87%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

The Stellar Crown Medicham ex (#161) currently trades at €1.07 in the raw market. Its 30-day price movement has declined (-31.4%). By market value it ranks #43 of 175 in Stellar Crown — the 75th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated high. Read together, a upper-tier ranking in Stellar Crown alongside softening 30-day momentum frames where Medicham ex sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.